amivantamab
janssen,genmab
['chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)']
. presents metex14 cohort from chrysalis. n=55. median 3 prior lines of treatment for those met pretreated. interesting. orrs met untreated 47% and 17% met pretreated. responses early generally with first ct. safety as prior. interesting and encouraging data #asco22 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own. Wear a mask, keep distant, get the vaccine & then a booster!